Topic

Articles

Carolynn Johnson talks about changing the diversity, equity and includsion trends among the most progressive companies.

Mentoring with a Different Lens: Insights with DiversityInc CEO Carolynn Johnson

Dr. Frank Douglas graduated with a B.S. in Engineering from Lehigh University in 1966. He went on to a Ph.D. in Physical Chemistry from Cornell University, with a thesis on chlorophyll-a. After a medical degree from Cornell University Medical School, he completed an internship and residency in internal medicine at Johns Hopkins Medical Institution and a fellowship in neuroendocrinology at the National Institutes of Health.

Following his fellowship, Douglas took a position as an assistant professor of medicine at the University of Chicago. He also began work at the pharma company Ciba-Geigy. In 1992, he became an executive vice president at Marion Merrell Dow, where he remained as it was acquired and changed names to Hoechst Marion Roussel, and later to Aventis. 

In 2005, Douglas left Aventis and took a position as a professor of the practice at Massachusetts Institute of Technology, where he was involved in founding the Center for Biomedical Innovation. After two years at MIT, he resigned over concerns about institutional racism. In 2009, Douglas moved to Akron, Ohio to serve as president and CEO of the Austen BioInnovation Institute. He left the institute at the beginning of 2015. 

Douglas published an autobiography in 2018, 

Defining Moments of a Free Man from a Black Stream.

How can large pharma improve D&I in its companies?

Addressing Systemic Racism in Biopharma

Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mjhlifesciences.com

Soft skills are needed to round out the hard numbers.

Data Science Calls for Shift in Executive Leadership Methods

Examining the incumbent and imminent workforce.

Talent & Careers 2022

If not addressed, effects could impact innovation, diversity.

More Jobs and Less Talent Has Created an Imbalance in Pharma

Landmark Bio CEO Ran Zheng talks about the value of collaborating with best-in-class partners.

Orchestrating a Life Sciences Ecosystem Where Everyone is an A-Player: Insights with Landmark Bio’s Ran Zheng

Vice President, Quality, Acceleron Pharma Inc.

Fellow, Institute for Inclusive Leadership, Professor of Practice (Retired), School of Business, Simmons University

Using the interview process to ensure high organizational standards.

How GxP Leaders Can Assess and Approach a Company’s Quality Culture

Dr. Randall N. Hyer, SVP Global Medical Affairs at Moderna, talks about the strategies that have helped the company grow from startup to multi-billion-dollar firm in a decade.

Determining the Right Combination of Employees and New Technologies at Moderna

For leaders, shifting mindsets and altering dynamics can help.

Pandemic Heightens Concern Over Workplace Burnout

Insights from AmerisourceBergen EVP and Chief Strategy Officer, Leslie Donato.